An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis.

Prajapati, Vijay Kumar; Awasthi, Kalpna; Yadav, Thakur Prasad; Rai, Madhukar; Srivastava, Onkar Nath; Sundar, Shyam

Prajapati, Vijay Kumar; Awasthi, Kalpna; Yadav, Thakur Prasad; Rai, Madhukar; Srivastava, Onkar Nath; Sundar, Shyam.

Affiliation

Prajapati VK; Department of Medicine, Infectious Disease Research Laboratory, Institute of Medical Sciences, Banaras Hindu University,Varanasi, India.

J Infect Dis ; 205(2): 333-6, 2012 Jan 15.

Article in En | MEDLINE | ID: mdl-22158723

Subject(s)

Amphotericin B/administration & dosage; Antiprotozoal Agents/administration & dosage; Leishmania donovani; Leishmaniasis, Visceral/drug therapy; Nanotubes, Carbon; Splenic Diseases/drug therapy; Administration, Oral; Amphotericin B/therapeutic use; Animals; Antiprotozoal Agents/therapeutic use; Chemistry, Pharmaceutical; Cricetinae; Drug Carriers; Leishmaniasis, Visceral/parasitology; Male; Parasite Load; Splenic Diseases/parasitology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Splenic Diseases / Leishmania donovani / Amphotericin B / Nanotubes, Carbon / Leishmaniasis, Visceral / Antiprotozoal Agents Limits: Animals Language: En Journal: J Infect Dis Year: 2012 Type: Article Affiliation country: India

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google